Patents by Inventor Christopher Taron

Christopher Taron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7390636
    Abstract: Methods and compositions are provided relating to production of recombinant protein in yeast. A modified PLAC4 is described where one or more mutations may be introduced into the Pribnow box-like sequences in the promoter. The modified promoter when placed upstream of a target gene in a vector causes a significant reduction of target gene expression in transformed bacteria but produces efficient expression of the target gene in yeast.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: June 24, 2008
    Assignee: New England Biolabs, Inc.
    Inventors: Christopher Taron, Paul Colussi
  • Publication number: 20070065880
    Abstract: Compositions and methods are provided for creating and identifying mutant carbohydrate-binding proteins that reversibly bind to carbohydrate substrates under conditions where the native protein remains bound. Examples of modified chitin-binding domains are provided which can be eluted from chitin in the presence of a reducing agent or at a pH within the range of 5-10.
    Type: Application
    Filed: September 20, 2006
    Publication date: March 22, 2007
    Applicant: New England Biolabs, Inc.
    Inventors: Christopher Taron, Paul Colussi, Jeremiah Read
  • Publication number: 20060199225
    Abstract: Compositions and methods are provided for reversibly binding chitin-binding domain (CBD) to a chitin or equivalent substrate under non-denaturing conditions. CBD from either prokaryotes or eukaryotes are modified for example, by random mutation, and screened to identify mutants that achieve this change in properties. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD that binds irreversibly to chitin.
    Type: Application
    Filed: February 21, 2006
    Publication date: September 7, 2006
    Applicant: New England Biolabs, Inc.
    Inventors: Paul Colussi, Jeremiah Read, Ming-qun Xu, Christopher Taron
  • Publication number: 20060035333
    Abstract: Methods and compositions are described that relate to obtaining concentrated preparations of secreted recombinant proteins. These proteins are expressed in the form of fusion proteins with a chitin-binding domain (CBD). The fusion proteins are capable of being concentrated in the presence of chitin. Also described is: a shuttle vector that includes a modified LAC4 promoter; a chitinase-negative host cell; a CBD capable of eluting from chitin under non-denaturing conditions; and sterilized chitin, which can be optionally magnetized for facilitating recovery of recombinant protein.
    Type: Application
    Filed: October 3, 2005
    Publication date: February 16, 2006
    Applicant: New England Biolabs, Inc.
    Inventors: Christopher Taron, Paul Colussi
  • Publication number: 20060030008
    Abstract: Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
    Type: Application
    Filed: September 26, 2005
    Publication date: February 9, 2006
    Applicant: New England Biolabs, Inc.
    Inventors: Ming-Qun Xu, Sebastien Ferrandon, Christopher Taron, Paul Colussi
  • Publication number: 20050227326
    Abstract: Methods and compositions are provided relating to production of recombinant protein in yeast. A modified PLAC4 is described where one or more mutations may be introduced into the Pribnow box-like sequences in the promoter. The modified promoter when placed upstream of a target gene in a vector causes a significant reduction of target gene expression in transformed bacteria but produces efficient expression of the target gene in yeast.
    Type: Application
    Filed: April 8, 2005
    Publication date: October 13, 2005
    Inventors: Christopher Taron, Paul Colussi